BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 19861445)

  • 1. Quantification of circulating vascular endothelial growth factor receptor-3-positive lymphatic/vascular endothelial progenitor cells.
    Farace F; Taylor M; Rössler J; Loriot Y; Besse B
    Clin Cancer Res; 2009 Nov; 15(21):6740; author reply 6740-1. PubMed ID: 19861445
    [No Abstract]   [Full Text] [Related]  

  • 2. High VEGFR-3-positive circulating lymphatic/vascular endothelial progenitor cell level is associated with poor prognosis in human small cell lung cancer.
    Bogos K; Renyi-Vamos F; Dobos J; Kenessey I; Tovari J; Timar J; Strausz J; Ostoros G; Klepetko W; Ankersmit HJ; Lang G; Hoda MA; Nierlich P; Dome B
    Clin Cancer Res; 2009 Mar; 15(5):1741-6. PubMed ID: 19240177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular endothelial growth factor-C and C-C chemokine receptor 7 in tumor cell-lymphatic cross-talk promote invasive phenotype.
    Issa A; Le TX; Shoushtari AN; Shields JD; Swartz MA
    Cancer Res; 2009 Jan; 69(1):349-57. PubMed ID: 19118020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sumoylation of Prox1 controls its ability to induce VEGFR3 expression and lymphatic phenotypes in endothelial cells.
    Pan MR; Chang TM; Chang HC; Su JL; Wang HW; Hung WC
    J Cell Sci; 2009 Sep; 122(Pt 18):3358-64. PubMed ID: 19706680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COUP-TFII regulates the functions of Prox1 in lymphatic endothelial cells through direct interaction.
    Yamazaki T; Yoshimatsu Y; Morishita Y; Miyazono K; Watabe T
    Genes Cells; 2009 Mar; 14(3):425-34. PubMed ID: 19210544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating endothelial progenitor cells.
    Ott HC; Taylor DA
    N Engl J Med; 2005 Dec; 353(24):2613-6; author reply 2613-6. PubMed ID: 16363025
    [No Abstract]   [Full Text] [Related]  

  • 7. Retiform hemangioendotheliomas usually do not express D2-40 and VEGFR-3.
    Parsons A; Sheehan DJ; Sangueza OP
    Am J Dermatopathol; 2008 Feb; 30(1):31-3. PubMed ID: 18212541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VEGFR-3 expression is restricted to blood and lymphatic vessels in solid tumors.
    Petrova TV; Bono P; Holnthoner W; Chesnes J; Pytowski B; Sihto H; Laakkonen P; Heikkilä P; Joensuu H; Alitalo K
    Cancer Cell; 2008 Jun; 13(6):554-6. PubMed ID: 18538738
    [No Abstract]   [Full Text] [Related]  

  • 9. Circulating endothelial cells as biomarkers of prostate cancer.
    Georgiou HD; Namdarian B; Corcoran NM; Costello AJ; Hovens CM
    Nat Clin Pract Urol; 2008 Aug; 5(8):445-54. PubMed ID: 18682720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The influence of hyperglycemia on functions of endothelial progenitor cells].
    Krawczyk A; Izdebska M; Grzanka A
    Pol Merkur Lekarski; 2009 Mar; 26(153):245-7. PubMed ID: 19388542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal Shh and FOXC2 expression correlates with aberrant lymphatic development in human fetuses with increased nuchal translucency.
    de Mooij YM; van den Akker NM; Bekker MN; Bartelings MM; Wisse LJ; van Vugt JM; Gittenberger-de Groot AC
    Prenat Diagn; 2009 Sep; 29(9):840-6. PubMed ID: 19548265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphangioleiomyoma cells and lymphatic endothelial cells: expression of VEGFR-3 in lymphangioleiomyoma cell clusters.
    Seyama K; Mitani K; Kumasaka T; Gupta SK; Oommen S; Liu G; Ryu JH; Vlahakis NE
    Am J Pathol; 2010 Apr; 176(4):2051-2; author reply 2052-4. PubMed ID: 20203284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VEGFR2-PLCgamma1 axis is essential for endothelial specification of VEGFR2+ vascular progenitor cells.
    Sase H; Watabe T; Kawasaki K; Miyazono K; Miyazawa K
    J Cell Sci; 2009 Sep; 122(Pt 18):3303-11. PubMed ID: 19706681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphatic phenotype of tumour vessels in malignant gliomas.
    Grau SJ; Trillsch F; von Lüttichau I; Nelson PJ; Herms J; Tonn JC; Goldbrunner RH
    Neuropathol Appl Neurobiol; 2008 Dec; 34(6):675-9. PubMed ID: 19076698
    [No Abstract]   [Full Text] [Related]  

  • 15. Circulating progenitors in lung injury: a novel therapy for acute respiratory distress syndrome?
    Burnham EL
    Anesthesiology; 2008 Mar; 108(3):354-6. PubMed ID: 18292671
    [No Abstract]   [Full Text] [Related]  

  • 16. [Relation between vascular endothelial growth factor and lung cancer].
    Chen GY; Hong X
    Zhonghua Zhong Liu Za Zhi; 2005 Aug; 27(8):449-51. PubMed ID: 16188137
    [No Abstract]   [Full Text] [Related]  

  • 17. Rapid and large increase of the frequency of circulating endothelial colony-forming cells (ECFCs) generating late outgrowth endothelial cells in patients with acute myocardial infarction.
    Massa M; Campanelli R; Bonetti E; Ferrario M; Marinoni B; Rosti V
    Exp Hematol; 2009 Jan; 37(1):8-9. PubMed ID: 19013004
    [No Abstract]   [Full Text] [Related]  

  • 18. Dual role of parathyroid hormone in endothelial progenitor cells and marrow stromal mesenchymal stem cells.
    Di Bernardo G; Galderisi U; Fiorito C; Squillaro T; Cito L; Cipollaro M; Giordano A; Napoli C
    J Cell Physiol; 2010 Feb; 222(2):474-80. PubMed ID: 19918796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A truncated erythropoietin receptor EPOR-T is associated with hypertension susceptibility.
    Carruthers SG
    Clin Pharmacol Ther; 2009 Aug; 86(2):134-6. PubMed ID: 19621008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial progenitor cells: pathogenetic role and therapeutic perspectives.
    Allegra A; Coppolino G; Bolignano D; Giacobbe MS; Alonci A; D'Angelo A; Bellomo G; Teti D; Loddo S; Musolino C; Buemi M
    J Nephrol; 2009; 22(4):463-75. PubMed ID: 19662601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.